Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electrocardiography | 5 | 2023 | 279 | 1.290 |
Why?
|
| Bundle of His | 4 | 2023 | 7 | 0.980 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 200 | 0.880 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 8 | 0.630 |
Why?
|
| Bundle-Branch Block | 2 | 2020 | 19 | 0.620 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2023 | 34 | 0.620 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 98 | 0.590 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2018 | 1 | 0.570 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 154 | 0.560 |
Why?
|
| Catheter Ablation | 1 | 2019 | 125 | 0.560 |
Why?
|
| Coronary Aneurysm | 1 | 2016 | 19 | 0.480 |
Why?
|
| Heart Failure | 4 | 2024 | 565 | 0.470 |
Why?
|
| Echocardiography | 1 | 2018 | 415 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 321 | 0.440 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2020 | 21 | 0.310 |
Why?
|
| Heart Ventricles | 2 | 2019 | 264 | 0.250 |
Why?
|
| Hospitalization | 3 | 2024 | 739 | 0.210 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 63 | 0.210 |
Why?
|
| Humans | 15 | 2024 | 52114 | 0.200 |
Why?
|
| Bradycardia | 1 | 2023 | 38 | 0.190 |
Why?
|
| Electric Countershock | 1 | 2022 | 30 | 0.180 |
Why?
|
| Atrial Appendage | 1 | 2021 | 14 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2021 | 276 | 0.180 |
Why?
|
| Registries | 1 | 2024 | 629 | 0.170 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 177 | 0.170 |
Why?
|
| Aminobutyrates | 1 | 2021 | 3 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 22 | 0.170 |
Why?
|
| Tetrazoles | 1 | 2021 | 41 | 0.170 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2021 | 36 | 0.170 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 6 | 0.160 |
Why?
|
| Renal Dialysis | 1 | 2021 | 190 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2021 | 229 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 121 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 40 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 317 | 0.130 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.130 |
Why?
|
| Stroke | 1 | 2021 | 514 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 25 | 0.120 |
Why?
|
| Health Policy | 1 | 2017 | 160 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 44 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1070 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2017 | 451 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2023 | 5456 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 318 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2016 | 225 | 0.100 |
Why?
|
| Aged | 3 | 2024 | 10142 | 0.090 |
Why?
|
| Risk Factors | 2 | 2021 | 3922 | 0.090 |
Why?
|
| Middle Aged | 3 | 2024 | 13028 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2021 | 159 | 0.080 |
Why?
|
| Female | 4 | 2024 | 28055 | 0.070 |
Why?
|
| Male | 3 | 2024 | 26652 | 0.060 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 31 | 0.050 |
Why?
|
| Adult | 1 | 2019 | 14095 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2024 | 108 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2023 | 25 | 0.050 |
Why?
|
| Electrodes | 1 | 2022 | 34 | 0.050 |
Why?
|
| Telemetry | 1 | 2021 | 27 | 0.040 |
Why?
|
| Tachycardia | 1 | 2021 | 28 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2021 | 31 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 31 | 0.040 |
Why?
|
| Indiana | 1 | 2020 | 12 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 134 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 104 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 1541 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 162 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 207 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2021 | 384 | 0.040 |
Why?
|
| Heart Rate | 1 | 2021 | 317 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 2282 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 939 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1665 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1035 | 0.030 |
Why?
|
| Nevada | 1 | 2017 | 2 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1339 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 113 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 328 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6610 | 0.020 |
Why?
|